Technical Analysis for MRKR - Marker Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.97 0.51% 0.01
MRKR closed up 0.51 percent on Wednesday, July 8, 2020, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical MRKR trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 0.51%
Bollinger Band Squeeze Range Contraction 0.51%
Down 3 Days in a Row Weakness 0.51%
20 DMA Resistance Bearish -0.51%
Bollinger Band Squeeze Range Contraction -0.51%
Fell Below 20 DMA Bearish -4.83%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its cell therapy technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is also advancing various peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including its Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In addition, it develops a proprietary DNA expression technology, known as PolyStart, to improve the ability of the cellular immune system to recognize and destroy diseased cells. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Medicine Cancer Immunology Oncology Treatment Of Cancer Immunotherapy Immune System Cancer Treatments Virotherapy Cancer Immunotherapy Tumor Immunotherapies Cell Therapy Solid Tumor Hematological Malignancies T Cell

Is MRKR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.17
52 Week Low 1.33
Average Volume 576,399
200-Day Moving Average 2.85
50-Day Moving Average 2.26
20-Day Moving Average 2.07
10-Day Moving Average 2.03
Average True Range 0.15
ADX 9.65
+DI 17.82
-DI 21.24
Chandelier Exit (Long, 3 ATRs ) 1.99
Chandelier Exit (Short, 3 ATRs ) 2.33
Upper Bollinger Band 2.22
Lower Bollinger Band 1.91
Percent B (%b) 0.18
BandWidth 14.95
MACD Line -0.07
MACD Signal Line -0.06
MACD Histogram -0.0026
Fundamentals Value
Market Cap 20.01 Million
Num Shares 10.2 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -1.93
Price-to-Sales 0.00
Price-to-Book 3.74
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.12
Resistance 3 (R3) 2.12 2.06 2.10
Resistance 2 (R2) 2.06 2.03 2.07 2.09
Resistance 1 (R1) 2.02 2.00 1.99 2.02 2.08
Pivot Point 1.96 1.96 1.95 1.97 1.96
Support 1 (S1) 1.92 1.93 1.89 1.92 1.86
Support 2 (S2) 1.86 1.90 1.87 1.85
Support 3 (S3) 1.82 1.86 1.85
Support 4 (S4) 1.82